The global large molecule drug discovery outsourcing market size is expected to reach USD 8.13 Billion in 2034 from USD 3.50 Billion in 2025, growing at a CAGR of 9.82 during 2026-2034.This market is growing rapidly as pharmaceutical and biotechnology companies increasingly outsource drug discovery activities to specialized service providers. Large molecule drug discovery involves the development of biologics such as monoclonal antibodies, recombinant proteins, vaccines, and cell-based therapies.
